IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

OLMASTRONI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.442
AS - Asia 4.336
EU - Europa 4.268
SA - Sud America 710
AF - Africa 278
OC - Oceania 156
Totale 14.190
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.996
CN - Cina 1.286
IT - Italia 1.203
SG - Singapore 888
DE - Germania 636
GB - Regno Unito 451
BR - Brasile 421
HK - Hong Kong 334
VN - Vietnam 300
RU - Federazione Russa 260
ES - Italia 254
IN - India 240
CA - Canada 234
FR - Francia 234
JP - Giappone 198
NL - Olanda 182
SE - Svezia 157
ID - Indonesia 151
TW - Taiwan 146
AU - Australia 144
FI - Finlandia 139
MX - Messico 139
KR - Corea 133
TR - Turchia 131
EG - Egitto 128
PL - Polonia 116
IE - Irlanda 106
CO - Colombia 105
TH - Thailandia 99
AT - Austria 74
BD - Bangladesh 74
IR - Iran 69
AR - Argentina 62
DK - Danimarca 58
CH - Svizzera 55
PT - Portogallo 53
BE - Belgio 45
PE - Perù 42
SA - Arabia Saudita 41
CI - Costa d'Avorio 39
GR - Grecia 37
PK - Pakistan 37
ZA - Sudafrica 33
CL - Cile 30
RO - Romania 30
EC - Ecuador 27
DO - Repubblica Dominicana 26
MY - Malesia 25
CZ - Repubblica Ceca 24
PH - Filippine 24
AE - Emirati Arabi Uniti 23
IL - Israele 23
IQ - Iraq 19
JO - Giordania 19
SI - Slovenia 19
NO - Norvegia 18
UA - Ucraina 18
HU - Ungheria 16
KZ - Kazakistan 16
RS - Serbia 15
CR - Costa Rica 14
BG - Bulgaria 12
MA - Marocco 12
NZ - Nuova Zelanda 12
ET - Etiopia 11
KE - Kenya 11
AL - Albania 10
IS - Islanda 10
LT - Lituania 10
TN - Tunisia 9
NG - Nigeria 8
VE - Venezuela 8
LY - Libia 7
PR - Porto Rico 7
UY - Uruguay 7
UZ - Uzbekistan 7
GE - Georgia 6
KW - Kuwait 6
NP - Nepal 6
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
JM - Giamaica 5
LB - Libano 5
RE - Reunion 5
SC - Seychelles 5
BO - Bolivia 4
HR - Croazia 4
KG - Kirghizistan 4
LV - Lettonia 4
MO - Macao, regione amministrativa speciale della Cina 4
PY - Paraguay 4
SD - Sudan 4
SY - Repubblica araba siriana 4
BA - Bosnia-Erzegovina 3
CU - Cuba 3
CY - Cipro 3
EE - Estonia 3
OM - Oman 3
PA - Panama 3
QA - Qatar 3
Totale 14.160
Salva come PNG Salva come JPEG
Città #
Singapore 494
Ashburn 358
Milan 265
Hong Kong 256
San Jose 222
Frankfurt am Main 193
Beijing 169
Southend 161
Hanover 157
Dallas 152
Los Angeles 141
Hefei 128
New York 122
Council Bluffs 117
Chandler 112
Cairo 105
Ho Chi Minh City 96
Rome 92
Dublin 89
Helsinki 85
Istanbul 77
Hanoi 72
Bangkok 70
Bengaluru 67
Jakarta 64
Moscow 64
Fairfield 62
Santa Clara 61
Tokyo 61
Guangzhou 57
Chicago 56
Houston 56
São Paulo 55
Shanghai 53
Munich 52
Bogotá 50
Atlanta 49
Wilmington 49
Taipei 47
Toronto 46
Vienna 46
Madrid 45
Sydney 44
Idaho Falls 43
Lauterbourg 43
Melbourne 43
Seoul 43
Buffalo 40
Denver 40
Princeton 40
Seattle 40
Abidjan 39
Redwood City 39
Turin 38
Warsaw 38
Salt Lake City 37
Ann Arbor 35
London 35
Des Moines 33
Lima 32
Montreal 32
Naples 32
Paris 32
Nanjing 30
San Diego 30
Boston 28
Taichung 28
Woodbridge 28
Amsterdam 26
Cambridge 26
Pittsburgh 26
Santiago 25
The Dalles 24
Barcelona 23
Brasília 23
Buenos Aires 23
Guadalajara 23
Orem 23
Bari 22
Boardman 22
Indianapolis 22
Stockholm 22
Tehran 22
Birmingham 21
Brooklyn 21
Da Nang 21
Wuhan 21
Brussels 20
Manchester 20
Nuremberg 20
Winnipeg 20
Zaragoza 20
Central 19
Chengdu 19
Chennai 19
Grafing 19
Kaohsiung City 19
Santo Domingo 19
Tampa 19
Amman 18
Totale 6.402
Salva come PNG Salva come JPEG
Nome #
Statin use and risk of dementia or Alzheimer's disease : a systematic review and meta-analysis of observational studies 5.967
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 928
Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: need for customisation strategies 436
Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study 314
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting : the PROSISA Study 280
Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study 239
Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study) 238
Gut microbiota functional dysbiosis relates to individual diet in subclinical carotid atherosclerosis 231
USE OF MENDELIAN RANDOMIZATION STUDIES TO IDENTIFY POSSIBLE PHARMACOLOGICAL TARGETS IN THE CARDIOVASCULAR AREA 219
Multilevel Models to Estimate Carotid Intima-Media Thickness Curves for Individual Cardiovascular Risk Evaluation 218
Global epidemiology of dyslipidaemias 216
Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review 215
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub-study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) 201
Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study 190
Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies 190
Epidemiology of cardiovascular risk factors in two population-based studies 169
Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials 168
Cardiovascular events with PCSK9 inhibitors : an updated meta-analysis of randomised controlled trials 164
Global perspective of familial hypercholesterolaemia : a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 163
Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment 161
Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials 160
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 159
Longevity-associated BPIFB4 gene counteracts the inflammatory signaling. 158
Adherence to the Mediterranean Diet: Impact of Geographical Location of the Observations 154
How registers could enhance knowledge and characterization of genetic dyslipidaemias : The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia 151
Effect on C‐reactive protein levels of the addition of ezetimibe, bempedoic acid, or colchicine to statin treatment: A network meta‐analysis 149
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 142
Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions-The EDU.RE.DRUG Project 140
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 140
Potentially Inappropriate Prescribing among Elderly Outpatients: Evaluation of Temporal Trends 2012–2018 in Piedmont, Italy 133
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 131
Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) andtriglyceride-rich lipoprotein metabolism: Facts and gaps 129
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries 122
Operational Definitions of Polypharmacy and Their Association with All-Cause Hospitalization Risk: A Conceptual Framework Using Administrative Databases 122
Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review 113
Plasma proteins associate with carotid plaques and predict incident atherosclerotic cardiovascular events 113
A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: Design and rationale of the EDU.RE.DRUG study 109
Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies 108
Lipoprotein(a) and prothrombotic effects: Evidence from a genetic association study 107
Antibiotic Prescription in the Community-Dwelling Elderly Population in Lombardy, Italy: A Sub-Analysis of the EDU.RE.DRUG Study 104
Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia 104
Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study 103
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 99
Ezetimibe: Integrating Established Use with New Evidence - A Comprehensive Review 89
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 84
A newly developed method for assessing co-exposure to free dose combinations: a proof-of-concept study using antihypertensive medications in Danish registers 83
Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy's first wave of the COVID-19 pandemic 81
Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry 79
Attitudes and confidence toward deprescribing: a survey among Italian general practitioners 75
Enhancing Medication Adherence in Older Adults: A Systematic Review of Evidence‐Based Strategies 50
Colchicine and cardiovascular events: An updated meta-analysis of published randomized controlled trials 49
Contribution and interaction of polygenic predisposition and family history of coronary heart disease in predicting cardiovascular risk 43
CX3CR1-T280M polymorphism and end-stage renal disease development in chronic kidney disease. 8
Totale 14.498
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 0 57 52
2021/2022741 39 51 50 66 64 59 56 45 80 86 52 93
2022/20231.191 59 60 55 89 79 107 115 117 158 101 162 89
2023/20242.591 132 165 162 289 332 157 154 141 394 181 235 249
2024/20253.855 241 349 243 303 319 230 270 348 336 350 388 478
2025/20265.198 545 438 550 486 465 325 690 279 600 469 351 0
Totale 14.498